Ann: Immutep Quarterly Activities Report and Appendix 4C, page-17

howdy yd, the very first trial with efti/imp321 and keytruda was in OZ with immutep
using Australia's PBS scheme to buy keytruda for melanoma combo trials run out of
Greenslopes hospital under Dr Victoria Anderson, from there it graduated to a
collaboration with Merck with Merck supplying up to $18M of keytruda for NCSLC
and Head and Neck cancer.....
Head and Neck cancer has since been given fast track status at immuteps request,
at no stage that we have been made aware of has Merck been given access to "efti"..
IMO there is ample funds to get a decision on the fast track whereby Merck may choose
to make a financial transaction with Immutep...
Aipac will soak up funds like there is no tomorrow and I doubt immuteps structure at
the moment has the capacity to take it too far without assistance...